Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival

Figure 2 Cumulative survival rates of hepatocellular carcinoma patients following radiofrequency ablation treatment. Comparisons are presented between the following patient sub-groups. A: Male and female; B: Tumor size of ≤ 35 mm and > 35 mm; C: Child-Pugh A and B; D: Model for end-stage liver disease score ≤ 11 and > 11; E: Complete and partial initial response; F: With tumor recurrence and without tumor recurrence.